Pharmacogenomic samples, testing and data handling

  • Email
  • Help
Current version

Reflection paper

Reference numberEMEA/CHMP/PGxWP/201914/06
Published15/11/2007
KeywordsPharmacogenomics (PG), pharmacogenomic evaluation
DescriptionThis document highlights some key principles to be considered by both the pharmaceutical industry and the assessors for pharmacogenomics sampling in clinical trials intended for regulatory submission.


Document history

First version

Current version

Reflection paper


Overview of comments

Published: 15/11/2007


Published: 02/04/2007


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more